Myeloid Lymphoid Neoplasm with Eosinophilia and Pdgfra Rearrangement
📧 Sign up to get email alerts when something new happens for Myeloid Lymphoid Neoplasm with Eosinophilia and Pdgfra Rearrangement.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-08-17FDA Approved: IMATINIB MESYLATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva's supplemental application for imatinib mesylate, a generic version of the cancer drug, to update its approval status.